Active — Not RecruitingNot Applicable

Home-based EXercise and motivAtional Program Before and After Liver Transplantation

United Kingdom269 participantsStarted 2022-05-03

Plain-language summary

Liver disease is the 3rd commonest cause of death in adults of working age and liver transplantation (LT) remains the only cure for liver failure. LT exerts a huge stress on the body and mind, especially in people who are already physically and mentally frail because of their liver disease. Investigators know that being physically frailty prior to surgery results in a longer hospital stay because of postoperative complications and contributes to 1 in 10 patients either dying whilst still on the waiting list or shortly after LT. Exercise is one of the most powerful medical therapies available, with numerous proven benefits to patients with diseases like diabetes, heart disease and cancer. Despite this, exercise is not currently used in patients with liver failure or recovering from LT, due to a lack of robust evidence. Exercise may have the potential to improve the lives of people with liver disease and reduce the side-effects of LT surgery. The current standard of care for NHS patients awaiting LT is an advice leaflet. Evidence-based exercise programmes around the time of transplantation do not exist. Only a few small studies have indicated that supervised, hospital-based exercise can improve physical function and quality of life. AIMS: Investigators aim to determine the effect of a home-based exercise and motivation-support programme in patients undergoing LT on their quality of life after surgery. Investigators would also like to understand if exercise results in improvements in intricate measures of physical fitness and muscle function that account for changes in quality of life, and how the motivation-support component of the intervention enhances uptake and ongoing engagement of exercise pre and post LT.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (aged 18 years or over) * Patients listed for a cadaveric, primary LT at QEUHB or the RFH * Being an out-patient at the time of baseline trial visit (consent) Exclusion Criteria: Patients listed for LT for any of the following reasons: * super-urgent LT (according to the Kings College criteria) * multi-organ transplantation (e.g. combined liver and kidney transplant) * live-related donor LT * re-graft LT Patients with an inability to safely comply with the exercise intervention due to: * severe hepatic encephalopathy (grade 3 or 4; or as judged by the clinical investigators) * oxygen-dependent hepato-pulmonary syndrome Patients without liver failure, including: * liver cancer in the absence of cirrhosis * polycystic liver disease * rare metabolic/genetic conditions (e.g. glycogen storage disorders) Refusal or lacks capacity to give informed consent to participate in the trial, at the point of study visit 1 (baseline)

What they're measuring

The physical component score (PCS) from the short form-36 version 2.0 (SF-36v2) health-related Quality of Life questionnaire

Timeframe: Baseline (visit 1, week 0) up to 24 weeks post-LT

Trial details

NCT IDNCT07063940

SponsorUniversity of Birmingham

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11